Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Campo · SciRah

Researcher profile · Semantic Scholar

R. Campo

Share profile

R. Campo — researcher profile on SciRah

h-index: 15
Works: 34
Citations: 2,091

Most-cited papers

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.
J. Gallant, E. Dejesus, J. Arribas, A. Pozniak +8 more
2006New England Journal of Medicine936 citations
Semantic Scholar
Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients: Virologic, Immunologic, and Morphologic Changes-A 96-Week Analysis
A. Pozniak, J. Gallant, E. Dejesus, J. Arribas +7 more
2006Journal of Acquired Immune Deficiency Syndromes246 citations Open access
Semantic Scholar
Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients: 144-Week Analysis
J. Arribas, A. Pozniak, J. Gallant, E. Dejesus +8 more
2008Journal of Acquired Immune Deficiency Syndromes240 citations Open access
Semantic Scholar
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial.
J. Molina, K. Squires, P. Sax, P. Cahn +134 more
2018The Lancet HIV136 citations
Semantic Scholar
Antiretrovirals and Weight Change: Weighing the Evidence.
D. Wohl, J. Koethe, P. Sax, G. McComsey +6 more
2024Clinical Infectious Diseases64 citations Open access
Semantic Scholar
Mycobacterium kansasii disease in patients infected with human immunodeficiency virus.
R. Campo, C. Campo
1997Clinical Infectious Diseases63 citations
Semantic Scholar
An Academic Center's Delivery of Care After the Haitian Earthquake
A. Jaffer, R. Campo, G. Gaski, Mario A Reyes +8 more
2010Annals of Internal Medicine54 citations Open access
Semantic Scholar
Infection Control in Field Hospitals after a Natural Disaster: Lessons Learned after the 2010 Earthquake in Haiti
Paola N. Lichtenberger, I. Miskin, G. Dickinson, M. Schwaber +6 more
2010Infection Control & Hospital Epidemiology53 citations
Semantic Scholar
SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen
R. Campo, E. Dejesus, U. Bredeek, K. Henry +11 more
2013Clinical Infectious Diseases47 citations Open access
Semantic Scholar
Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-Week Results from the REALMRK Study
K. Squires, L. Bekker, J. Eron, B. Cheng +14 more
2013AIDS Research and Human Retroviruses33 citations Open access
Semantic Scholar
Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients.
R. Campo, Rose Lalanne, T. Tanner, D. Jayaweera +3 more
2005AIDS (London)32 citations Open access
Semantic Scholar
Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients
R. Campo, C. Cohen, K. Grimm, T. Shangguan +2 more
2010International Journal of STD and AIDS25 citations
Semantic Scholar
Fulminant hepatitis from herpes simplex virus type 2 in an immunocompetent adult
L. Abbo, M. Alcaide, J. Paño, P. Robinson +1 more
2007Transplant Infectious Disease20 citations
Semantic Scholar
Predictors of Loss of Virologic Response in Subjects Who Simplified to Lopinavir/Ritonavir Monotherapy from Lopinavir/Ritonavir Plus Zidovudine/Lamivudine
R. Campo, B. D. da Silva, L. Cotte, J. Gathe +6 more
2009AIDS Research and Human Retroviruses19 citations
Semantic Scholar
Antiretroviral Treatment Considerations in Latino Patients
R. Campo, D. Alvarez, Guillermo Santos, J. Latorre
2005AIDS Patients Care and STDs18 citations
Semantic Scholar
Differences in Presentation and Outcome of Invasive Pneumococcal Disease among Patients with and without HIV Infection in the Pre-HAART Era
R. Campo, C. E. Campo, G. Peter, J. Zuleta +4 more
2005AIDS Patients Care and STDs14 citations
Semantic Scholar
Effectiveness and tolerability of a once‐daily amprenavir/ritonavir‐containing highly active antiretroviral therapy regimen in antiretroviral‐naïve patients at risk for nonadherence: 48‐week results after 24 weeks of directly observed therapy
D. Jayaweera, M. Kolber, M. Brill, T. Tanner +4 more
2004HIV Medicine12 citations
Semantic Scholar
Factors Influencing the Acceptance of Changes in Antiretroviral Therapy among HIV-1–Infected Patients
R. Campo, S. Narayanan, Patrick G. Clay, J. Dehovitz +5 more
2007AIDS Patients Care and STDs10 citations
Semantic Scholar
The causes of never events in hospitals
H. Gitlow, Qun Zuo, S. Ullmann, David Zambrana +3 more
20139 citations
Semantic Scholar
Efficacy of indinavir–ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failures
R. Campo, J. Moreno, G. Suarez, Nancimae Miller +8 more
2003AIDS (London)9 citations Open access
Semantic Scholar
A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)
J. Koethe, Jordan E. Lake, Amy Kantor, Laura M. Smeaton +12 more
2026Clinical Infectious Diseases8 citations Open access
Semantic Scholar
Erratum: SWIFT: Prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen (Clinical Infectious Diseases (2013) 56:11
R. Campo, E. Dejesus, U. Bredeek, K. Henry +2 more
20138 citations Open access
Semantic Scholar
Effect of Class-Specific Therapy Interruption on Persistence of HIV Type 1 Antiretroviral Resistance
R. Campo, Isabella Rosa, Paola N. Lichtenberger, G. Suarez +5 more
2003AIDS Research and Human Retroviruses8 citations
Semantic Scholar
Differences in the Frequency of Resistance to Antiretroviral Drug Classes among Human Immunodeficiency Virus Type 1 Clinical Isolates
R. Campo, Paola N. Lichtenberger, Isabella Rosa, G. Suarez +5 more
2003Journal of Clinical Microbiology8 citations Open access
Semantic Scholar
Development of Anti‐Retroviral Resistance of HIV‐1 Infected Individuals on Therapy: Is it inevitable?
M. Kolber, R. Campo, G. Dickinson
2004IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology7 citations
Semantic Scholar
The safety and efficacy of indinavir and ritonavir (400/400 mg BID) in HIV-1-infected individuals from an inner-city minority population: a pilot study
D. Jayaweera, Ernesto G. Scerpella, M. Robinson, R. Rode +5 more
2003International Journal of STD and AIDS4 citations
Semantic Scholar
Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).
R. Patarca, Alejandro Isava, R. Campo, Nelson J Rodriguez +17 more
2003Journal of Environmental Pathology And Toxicology4 citations
Semantic Scholar
Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).
R. Patarca, Alejandro Isava, R. Campo, Nelson J Rodriguez +17 more
2003Journal of Environmental Pathology And Toxicology3 citations
Semantic Scholar
Subcutaneous Nodules as a Dermatologic Manifestation of Bacteremia Due to Pseudomonas aeruginosa
R. Campo, K. Ratzan, S. Melnick
1994Southern medical journal (Birmingham, Ala. Print)2 citations
Semantic Scholar
Long-acting HIV Treatments: Study Design, Logistics, and Access
Nicholas A. Murdock, Nayri E Alajaji, R. Schaefer, C. A. Boone +12 more
2024Open Forum Infectious Diseases1 citations Open access
Semantic Scholar
Impact of resistance to antiretroviral therapy in the minority community.
Allan E. Rodriguez, R. Campo, J. Gathe, H. Kwakwa
2004The AIDS reader1 citations
Semantic Scholar
Cardiovascular Risk Assessment Using the Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score Model After Continuing or Switching to a Doravirine-Based HIV Treatment Regimen.
P. Hsue, G. Behrens, Zhi-Jin Xu, Yujie Zhao +4 more
2025Journal of Acquired Immune Deficiency Syndromes0 citations Open access
Semantic Scholar
HIV Drug Therapy in the Americas 16–18 April 2015, Mexico City, Mexico
M. Lederman, S. Bautista-Arredondo, S. Bertozzi, S. Sosa-Rubí +287 more
2015Journal of the International AIDS Society0 citations Open access
Semantic Scholar
Antiretroviral Therapy and Communities of Color
Kimberly Y. Smith, R. Campo
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Kolber×11
Invite
M. Kolber — researcher profile on SciRah
E. Dejesus×7
Invite
E. Dejesus — researcher profile on SciRah
D. Jayaweera×7
Invite
D. Jayaweera — researcher profile on SciRah
A. Pozniak×6
Invite
A. Pozniak — researcher profile on SciRah

Allan E. Rodriguez

×6

Invite

Allan E. Rodriguez — researcher profile on SciRah

Invite

J. Arribas — researcher profile on SciRah

Invite

B. Gazzard — researcher profile on SciRah

Invite

A. Cheng — researcher profile on SciRah

Pablo F Belaunzarán-Zamudio×4

Invite

Pablo F Belaunzarán-Zamudio — researcher profile on SciRah

J. Sierra-Madero×4

Invite

J. Sierra-Madero — researcher profile on SciRah

Invite

J. Gallant — researcher profile on SciRah

Invite

D. Mccoll — researcher profile on SciRah